Messieh Samuel S MD is categorized under Orthopedic Doctors and Physicians in Sebring, FL and active since 1996.
Messieh Samuel S MD was established in 1996, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Orthopedic Doctors and Physicians business, which does work in the B2C market, and is classified as a Orthopedic Doctors and Physicians, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Samuel Messieh at the company’s single location by writing to 6801 Us Highway 27 North # E5, Sebring, Florida FL 33870 or by phoning (863) 471-9700. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Messieh Samuel S MD |
| Contact Person: | Samuel Messieh |
| Address: | 6801 Us Highway 27 North # E5, Sebring, Florida 33870 |
| Phone Number: | (863) 471-9700 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1996 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Orthopedic Doctors and Physicians |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Messieh Samuel S MD was started in 1996 to provide professional Orthopedic Doctors and Physicians under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Samuel Messieh for inquiries that concern Messieh Samuel S MD by calling the company number (863) 471-9700, as your correspondence is most welcome. Additionally, the physical location of the single location of Messieh Samuel S MD can be found at the coordinates 27.5467,-81.50683 as well as the street address 6801 Us Highway 27 North # E5 in Sebring, Florida 33870.
For its online presence, you may visit Messieh Samuel S MD’s website at and engage with its social media outlets through on Twitter and on Facebook.